Aurora cannabis announces the completion of a multimillion dollar investment and renaming of b.c. manufacturing facility

Nasdaq | tsx: acb company's long-standing investment in operational excellence continues with industry leading upgrades  and renaming the facility to aurora alpine edmonton, ab , april 30, 2025 /prnewswire/ - aurora cannabis inc. (nasdaq: acb) (tsx: acb), the canadian-based leading global medical cannabis company, announces the completion of a multi-year investment of $3 million in improvements to its manufacturing facility in pemberton, british columbia. these upgrades are a combination of aurora's proprietary high-performing genetics and state-of-the-art engineering design which have resulted in optimal cultivation conditions, expanded output, and superior product quality.
ACB Ratings Summary
ACB Quant Ranking